MRSA (staph aureus) bacteremia 1. Vancomycin is first-line for sure 2. If vancomycin insensitive staph aureus (VISA) use DAPTOMYCIN 3. If fails daptomycin add ceftaroline

#Medtwitter We are thrilled to host Dr Sawyer Bawek, DO, incoming hemeonc fellow at CCF Hematology Oncology Fellows who will share his successful journey to fellowship match with rising #match2026 applicant Dr Dosbai Saparov 📅 February 25 ⏲️ 8pm -10 pm EST FREE zoom Link - us06web.zoom.us/j/89992347957?…

Fabulous turnout of 60+ #Match2026 Hemeonc fellowship applicants listening to Sawyer Bawek, DO, incoming star fellow at CCF Hematology Oncology Fellows. Thank you Dosbai Saparov for facilitating this insightful session for residents passionate about hemeonc 👏 ASH IMG Oncologists ASCO TECAG

H.O.M.E members meeting up at ASCO #ASCO25

Here is a recap of all the webinars we conducted for trainees interested to pursue #hemeonc fellowship. We are thrilled to grow to a community of 600+ residents/fellows across USA.

x.com/i/spaces/1YqKD…

Fitusiran Brand new idea degrades antithrombin by interfering with messenger RNA if you don't have messenger RNA remember you can't make proteins so it decreases the rate of needing transfusions clotting factors by 80 or 90%. It's like inducing the hypercoagulable state called

Happy July to all new fellows! 🎉 Fionnuala Crowley and I are excited to share our new article: Balancing the Scales: Real-Life Fellows’ Perspectives on Navigating Work-Life Balance in Oncology Training and Beyond | ASCO Connection connection.asco.org/do/balancing-s… We truly enjoyed writing

I just submitted my ERAS application for the Gastroenterology and Hepatology Fellowship, one of the most competitive fellowships in the US. I went through a lot during the last two years, living here alone and leaving the family behind with a new culture and health care system

📢 Now out in British Journal of Haematology 🎊🎉 Our latest work from the Princess Margaret Cancer Centre explores how GvHD prophylaxis influences the risk of second primary malignancies after allogeneic transplants using a large cohort of 1,418 patients (>6000 person-years of follow up) onlinelibrary.wiley.com/doi/10.1111/bj…

Efanesoctocog *Bioengineered protein that acts like human FVIII *Lasts MUCH longer

Emicizumab *Prevents or reduces bleeding episodes in people with hemophilia A *Both with and without inhibitors to factor VIII *Bispecific antibody *Bridges factor IXa and factor X, mimicking the function of factor VIII and facilitating blood clotting

Emicizumab Prophylaxis in Hemophilia A | New England Journal of Medicine nejm.org/do/10.1056/NEJ…

Today on #WorldBrainDay, let’s shine a light on mental health, an essential but often overlooked part of brain health. Mental illness is real. It’s treatable. And there’s no health without mental health. Let’s break the stigma, raise awareness, and promote compassion.

Treatment Algorithm: This is the algorithm we have used during our discussion with Andrew Kuykendall MD on Polycythemia Vera and Essential Thrombocythemia! #OncTwitter #MedTwitter #HemeTwitter OncUpdates

Honored to be selected as the Research Lead in the Hematology & Oncology Department. Grateful for the opportunity and excited to mentor, collaborate, and grow alongside an incredible team. Looking forward to the work ahead! #HemeOnc #Leadership #Mentorship #Research

🌟🇺🇸 #FDAApproval Alert🚨 📅 Aug 6, 2025 ➡️ The FDA has granted accelerated approval to dordaviprone (Modeyso) for H3 K27M-mutant diffuse midline glioma in pts ≥1 y/o with progression after prior therapy. This is the first systemic therapy approved for this indication. 🔬 🧪

These tips are helpful during the fellowship interviews as well!! Thanks for sharing with great tips for interviews!! 🙏🏻🙏🏻🔥 #Fellowship #Residency #Match #HemeOnc

#Match2026 Rising Future Hemeonc fellows Dosbai Saparov, Henry Becerra meeting up with other HOME Members at the Best of ASCO NYC conference!! 📚👨‍⚕️👩‍⚕️